Droms Strauss Advisors Inc Johnson & Johnson Transaction History

Droms Strauss Advisors Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$160.2 - $179.79 $185,511 - $208,196	1,158 New	1,158 $205,000
Q2 2022 Aug 11, 2022	BUY	$168.19 - $186.01 $2,859 - $3,162	17 Added 1.48%	1,168 $206,000
Q1 2022 May 23, 2022	BUY	$158.14 - $179.59 $182,019 - $206,708	1,151 New	1,151 $205,000
Q2 2021 Aug 06, 2021	SELL	$159.48 - $171.07 $249,426 - $267,553	-1,564 Closed	0 $0
Q1 2021 May 26, 2021	BUY	$153.07 - $170.48 $306 - $340	2 Added 0.13%	1,564 $257,000
Q4 2020 Jan 21, 2021	BUY	$137.11 - $157.38 $18,235 - $20,931	133 Added 9.31%	1,562 $247,000
Q3 2020 Jan 11, 2021	SELL	$140.38 - $153.83 $31,304 - $34,304	-223 Reduced 13.5%	1,429 $214,000
Q2 2020 Aug 12, 2020	SELL	$128.81 - $155.51 $36,195 - $43,698	-281 Reduced 14.54%	1,652 $233,000
Q1 2020 Apr 29, 2020	BUY	$111.14 - $153.99 $6,112 - $8,469	55 Added 2.93%	1,933 $254,000
Q4 2019 Jan 22, 2020	BUY	$127.5 - $146.44 $239,445 - $275,014	1,878 New	1,878 $275,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Droms Strauss Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Droms Strauss Advisors Inc with notifications on news.